Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
Clinical trial NCT05513729 · UNKNOWN
Trial details
- NCT number
- NCT05513729
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-18
- Primary completion
- 2023-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.